Literature DB >> 28522990

Animal Models for Tuberculosis in Translational and Precision Medicine.

Lingjun Zhan1,2,3,4,5, Jun Tang1,2,3,4,5, Mengmeng Sun1,2,3,4,5, Chuan Qin1,2,3,4,5.   

Abstract

Tuberculosis (TB) is a health threat to the global population. Anti-TB drugs and vaccines are key approaches for TB prevention and control. TB animal models are basic tools for developing biomarkers of diagnosis, drugs for therapy, vaccines for prevention and researching pathogenic mechanisms for identification of targets; thus, they serve as the cornerstone of comparative medicine, translational medicine, and precision medicine. In this review, we discuss the current use of TB animal models and their problems, as well as offering perspectives on the future of these models.

Entities:  

Keywords:  animal models; comparative medicine; precision medicine; translational medicine; tuberculosis

Year:  2017        PMID： 28522990      PMCID： PMC5415616          DOI： 10.3389/fmicb.2017.00717

Source DB:  PubMed          Journal:  Front Microbiol        ISSN： 1664-302X            Impact factor:   5.640


  114 in total

1.  Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma.

Authors:  Cristina Zanini; Francesco Pulerà; Franco Carta; Giuliana Giribaldi; Giorgia Mandili; Milena Maria Maule; Marco Forni; Franco Turrini
Journal:  Virchows Arch       Date:  2007-12-08       Impact factor: 4.064

2.  Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques.

Authors:  Philana Ling Lin; Veronique Dartois; Paul J Johnston; Christopher Janssen; Laura Via; Michael B Goodwin; Edwin Klein; Clifton E Barry; Joanne L Flynn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

Review 3.  Animal models of tuberculosis: Guinea pigs.

Authors:  Simon Clark; Yper Hall; Ann Williams
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-18       Impact factor: 6.915

4.  Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice.

Authors:  Delphine Nicolle; Cécile Fremond; Xavier Pichon; André Bouchot; Isabelle Maillet; Bernhard Ryffel; Valerie J F Quesniaux
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 5.  Immune markers and correlates of protection for vaccine induced immune responses.

Authors:  Aneesh Thakur; Lasse E Pedersen; Gregers Jungersen
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

6.  The hidden harm of home-based care: pulmonary tuberculosis symptoms among children providing home medical care to HIV/AIDS-affected adults in South Africa.

Authors:  Lucie Cluver; Mark Orkin; Mosa Moshabela; Caroline Kuo; Mark Boyes
Journal:  AIDS Care       Date:  2013-03-04

Review 7.  Six months therapy for tuberculous meningitis.

Authors:  Sophie Jullien; Hannah Ryan; Manish Modi; Rohit Bhatia
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

8.  Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.

Authors:  Ayşe Durnali; Saadet Tokluoğlu; Nuriye Özdemir; Mevlüde Inanç; Necati Alkiş; Nurullah Zengin; Özlem Uysal Sönmez; Mehmet Küçüköner
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 9.  Current Management of Primary Immune Thrombocytopenia.

Authors:  Drew Provan; Adrian C Newland
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

10.  PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis.

Authors:  Philana Ling Lin; Pauline Maiello; Hannah P Gideon; M Teresa Coleman; Anthony M Cadena; Mark A Rodgers; Robert Gregg; Melanie O'Malley; Jaime Tomko; Daniel Fillmore; L James Frye; Tara Rutledge; Robert M DiFazio; Christopher Janssen; Edwin Klein; Peter L Andersen; Sarah M Fortune; JoAnne L Flynn
Journal:  PLoS Pathog       Date:  2016-07-05       Impact factor: 6.823
View more
  17 in total

1.  Galleria mellonella - a novel infection model for the Mycobacterium tuberculosis complex.

Authors:  Yanwen Li; John Spiropoulos; William Cooley; Jasmeet Singh Khara; Camilla A Gladstone; Masanori Asai; Janine T Bossé; Brian D Robertson; Sandra M Newton; Paul R Langford
Journal:  Virulence       Date:  2018       Impact factor: 5.882

2.  A Modular Microscale Granuloma Model for Immune-Microenvironment Signaling Studies in vitro.

Authors:  Samuel B Berry; Maia S Gower; Xiaojing Su; Chetan Seshadri; Ashleigh B Theberge
Journal:  Front Bioeng Biotechnol       Date:  2020-08-18

Review 3.  Hit Generation in TB Drug Discovery: From Genome to Granuloma.

Authors:  Tianao Yuan; Nicole S Sampson
Journal:  Chem Rev       Date:  2018-01-31       Impact factor: 60.622

4.  Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence.

Authors:  Riti Sharan; Hee-Jeong Yang; Preeti Sule; Jeffrey D Cirillo
Journal:  J Vis Exp       Date:  2018-02-26       Impact factor: 1.355

5.  Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques.

Authors:  Sharie Keanne C Ganchua; Anthony M Cadena; Pauline Maiello; Hannah P Gideon; Amy J Myers; Beth F Junecko; Edwin C Klein; Philana Ling Lin; Joshua T Mattila; JoAnne L Flynn
Journal:  PLoS Pathog       Date:  2018-11-01       Impact factor: 6.823

6.  Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis.

Authors:  Sudhanshu Abhishek; Uma Nahar Saikia; Amod Gupta; Reema Bansal; Vishali Gupta; Nirbhai Singh; Suman Laal; Indu Verma
Journal:  Front Cell Infect Microbiol       Date:  2018-10-02       Impact factor: 5.293

7.  Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex.

Authors:  Masanori Asai; Yanwen Li; Jasmeet Singh Khara; Brian D Robertson; Paul R Langford; Sandra M Newton
Journal:  Front Microbiol       Date:  2019-11-20       Impact factor: 5.640

8.  Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.

Authors:  Nan Zhang; Natasha Strydom; Sandeep Tyagi; Heena Soni; Rokeya Tasneen; Eric L Nuermberger; Rada M Savic
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 9.  Indole Propionic Acid, an Unusual Antibiotic Produced by the Gut Microbiota, With Anti-inflammatory and Antioxidant Properties.

Authors:  Dereje Abate Negatu; Martin Gengenbacher; Véronique Dartois; Thomas Dick
Journal:  Front Microbiol       Date:  2020-10-27       Impact factor: 5.640

Review 10.  Challenges and recent progress in drug discovery for tropical diseases.

Authors:  Manu De Rycker; Beatriz Baragaña; Suzanne L Duce; Ian H Gilbert
Journal:  Nature       Date:  2018-07-25       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.